WELG.DE vs. CURE.DE
WELG.DE (Amundi S&P Global Health Care ESG UCITS ETF EUR Dist) and CURE.DE (VanEck Genomics and Healthcare Innovators UCITS ETF A) are both Health & Biotech Equities funds - WELG.DE tracks the S&P Developed Ex-Korea LargeMidCap Sustainability Enhanced Health Care while CURE.DE tracks the MVIS Global Future Healthcare ESG. Both are passively managed. Over the past 3 years, WELG.DE returned 2.22%/yr vs -2.48%/yr for CURE.DE. At a 0.49 correlation, their price movements are largely independent. WELG.DE charges 0.18%/yr vs 0.35%/yr for CURE.DE.
Performance
WELG.DE vs. CURE.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, WELG.DE achieves a -3.60% return, which is significantly higher than CURE.DE's -5.10% return.
WELG.DE
- 1D
- 2.97%
- 1M
- 3.72%
- YTD
- -3.60%
- 6M
- -3.07%
- 1Y
- 7.16%
- 3Y*
- 2.22%
- 5Y*
- —
- 10Y*
- —
CURE.DE
- 1D
- 4.01%
- 1M
- 6.73%
- YTD
- -5.10%
- 6M
- -8.62%
- 1Y
- 6.04%
- 3Y*
- -2.48%
- 5Y*
- —
- 10Y*
- —
WELG.DE vs. CURE.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
WELG.DE Amundi S&P Global Health Care ESG UCITS ETF EUR Dist | -3.60% | 1.26% | 7.51% | 1.94% | 4.13% |
CURE.DE VanEck Genomics and Healthcare Innovators UCITS ETF A | -5.10% | 5.09% | 0.30% | -6.42% | -3.35% |
Correlation
The correlation between WELG.DE and CURE.DE is 0.60, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.60 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.49 |
Correlation (All Time) Calculated using the full available price history since Oct 12, 2022 | 0.49 |
The correlation between WELG.DE and CURE.DE shifts across timeframes, from 0.49 (3 years) to 0.60 (1 year), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
WELG.DE vs. CURE.DE — Risk / Return Rank
WELG.DE
CURE.DE
WELG.DE vs. CURE.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Amundi S&P Global Health Care ESG UCITS ETF EUR Dist (WELG.DE) and VanEck Genomics and Healthcare Innovators UCITS ETF A (CURE.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| WELG.DE | CURE.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.18 | ||
| Sortino ratioReturn per unit of downside risk | +0.26 | ||
| Omega ratioGain probability vs. loss probability | 1.09 | 1.06 | +0.03 |
| Calmar ratioReturn relative to maximum drawdown | 0.55 | 0.30 | +0.25 |
| Martin ratioReturn relative to average drawdown | 1.29 | 0.68 | +0.61 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| WELG.DE | CURE.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.47 | 0.29 | +0.18 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.22 | -0.14 | +0.36 |
Drawdowns
WELG.DE vs. CURE.DE - Drawdown Comparison
The maximum WELG.DE drawdown since its inception was -23.11%, smaller than the maximum CURE.DE drawdown of -34.80%. Use the drawdown chart below to compare losses from any high point for WELG.DE and CURE.DE.
Loading charts...
Drawdown Indicators
| WELG.DE | CURE.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -23.11% | -34.80% | +11.69% |
Max Drawdown (1Y)Largest decline over 1 year | -12.38% | -19.07% | +6.69% |
Max Drawdown (3Y)Largest decline over 3 years | -23.11% | -29.32% | +6.21% |
Current DrawdownCurrent decline from peak | -12.09% | -15.66% | +3.57% |
Average DrawdownAverage peak-to-trough decline | -7.24% | -15.12% | +7.88% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.34% | 8.53% | -3.19% |
Volatility
WELG.DE vs. CURE.DE - Volatility Comparison
The current volatility for Amundi S&P Global Health Care ESG UCITS ETF EUR Dist (WELG.DE) is 5.31%, while VanEck Genomics and Healthcare Innovators UCITS ETF A (CURE.DE) has a volatility of 5.73%. This indicates that WELG.DE experiences smaller price fluctuations and is considered to be less risky than CURE.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| WELG.DE | CURE.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.31% | 5.73% | -0.42% |
Volatility (6M)Calculated over the trailing 6-month period | 10.25% | 15.20% | -4.95% |
Volatility (1Y)Calculated over the trailing 1-year period | 14.54% | 19.97% | -5.43% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 13.49% | 20.74% | -7.25% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 13.49% | 20.74% | -7.25% |
WELG.DE vs. CURE.DE - Expense Ratio Comparison
WELG.DE has a 0.18% expense ratio, which is lower than CURE.DE's 0.35% expense ratio.
Dividends
WELG.DE vs. CURE.DE - Dividend Comparison
WELG.DE's dividend yield for the trailing twelve months is around 1.55%, while CURE.DE has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
CURE.DE VanEck Genomics and Healthcare Innovators UCITS ETF A | 0.00% | 0.00% | 0.00% | 0.00% |
WELG.DE Amundi S&P Global Health Care ESG UCITS ETF EUR Dist | 1.55% | 1.36% | 0.92% | 0.17% |
Frequently Asked Questions
WELG.DE and CURE.DE have a correlation of 0.60, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, WELG.DE is cheaper at 0.18% per year. The better choice depends on whether you care most about return, fees, risk, or income.
WELG.DE is cheaper with a 0.18% expense ratio, compared with 0.35% for CURE.DE.
WELG.DE tracks S&P Developed Ex-Korea LargeMidCap Sustainability Enhanced Health Care, while CURE.DE tracks MVIS Global Future Healthcare ESG. They also come from different issuers: Amundi and VanEck. Their fees differ too: 0.18% for WELG.DE and 0.35% for CURE.DE.
Find the right allocation for WELG.DE and CURE.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer